Clinical Trial Update: Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

View source ↗

Summary

Clinical trial update describing considerations for patients in a Phase I treatment trial when deciding whether to participate in pharmacokinetic studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Leukemia
• Solid Tumor

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain and Central Nervous System Tumors, Leukemia | Status: COMPLETED